Recurrent Activating STAT5B N642H Mutation in Myeloid Neoplasms With Eosinophilia

Leukemia - United Kingdom
doi 10.1038/s41375-018-0342-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Uncovering the Molecular Basis for the Clinical N642H Mutation in STAT5B Using Atomistic Molecular Simulations

Biophysical Journal
Biophysics
2019English

Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Targeting Myeloid Cells to Prevent Recurrent Stroke in General Population: The Lesson of Hydroxyurea in Myeloproliferative Neoplasms

Blood Cancer Journal
OncologyHematology
2018English

Molecular Predictors of Response in Patients With Myeloid Neoplasms Treated With Lenalidomide

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

103 Therapy-Related Myeloid Neoplasms Following Treatment With Radioiodine

Leukemia Research
Cancer ResearchOncologyHematology
2011English

JARID2 Is a Tumor Suppressor in Myeloid Neoplasms

Cancer Discovery
Oncology
2018English

Myeloid Neoplasia and Lymphoblastic Lymphoma With Eosinophilia After RAI: A Case Report

Balkan Medical Journal
Medicine
2018English

Detection of Tryptase in Cytoplasmic Granules of Basophils in Patients With Chronic Myeloid Leukemia and Other Myeloid Neoplasms

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Targeted Next Generation Sequencing of PDGFRB Rearranged Myeloid Neoplasms With Monocytosis

American Journal of Hematology
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy